spacer gif spacer gif spacer gif spacer gif spacer gif
QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

Right arrow Help viewing high resolution images
Right arrow Return to article
(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.


Figure 3


Fig. 3. Characterization of the anti-pSer277 antibody as a potential phospho-specific AFAP-110 antibody. (A) Specificity of the newly generated phospho-specific AFAP-110 antibody was determined by dot-blot assay as described in Materials and Methods. NP, non-phosphorylated peptides; P, phosphorylated peptides. (B) Western blot analysis with the newly generated phospho-specific AFAP-110 antibody anti-pSer277. Samples were prepared as described in Fig. 2A,C, where a gel shift of the AFAP-110 protein band was observed in response to PMA treatment in western blot analysis. Here the western blot was probed with anti-pSer277 phospho-specific AFAP-110 antibody ({alpha}(P) AFAP, upper panel) or with an antibody against total AFAP-110 ({alpha}AFAP, lower panel) to control for equal expression of AFAP-110. (C) Time course of PMA-induced immunoreactivity with anti-pSer277 antibodies. GFP-AFAP-110 transfected COS-7 cells were treated with 100 nM PMA for the indicated time, prior to lysis in sample buffer, separation by SDS-PAGE and subsequent western blot analysis with anti-pSer277 ({alpha}(P) AFAP, upper panel). After stripping the membrane it was re-probed with a GFP antibody (lower panel), to control for equal loading. (D) Anti-pSer277 antibodies are immunoreactive with AFAP-110 in cells treated with PMA/PDBu. Anti-pSer277 antibody ({alpha}(P) AFAP, upper panel) recognizes PMA/PDBu-induced phosphorylation of overexpressed avian and human AFAP-110 as well as of endogenous human and rat AFAP-110 in western blot analysis. Overexpression of AFAP-110 was performed in COS-7 cells that had been lysed directly after PMA treatment. Endogenous AFAP-110 was immunoprecipitated after PMA treatment, as indicated, and SDS-PAGE and western blot analysis was performed. Membranes were probed with anti-pSer277 antibodies ({alpha}(P) AFAP, upper panel) and with a anti-AFAP antibody (lower panel), to control for equal loading. All western blots are labeled with molecular mass markers on the left.





Right arrow Return to article